The Clonidine Transdermal System, cataloged under National Stock Number 6505-01-224-3319, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Boehringer Ingelheim Pharmaceuticals Inc. Government technical data includes 3 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-224-3319 |
| Primary Part Number | 3112 |
| Item Name | Clonidine Transdermal System |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Boehringer Ingelheim Pharmaceuticals Inc |
| Status | ACTIVE |
| Usual Dose | 0.1 MG RELEASED PER DAYY FOR 7 DAYS |
| Features Provided | BANDAGE, ADHESIVE, NONSENSITIZED |
| Overall Strength in System | 2.55 MG CLONIDINE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| 3112 PRIMARY | Boehringer Ingelheim Pharmaceuticals Inc (USA) |
| NDC00597-0031-12 PRIMARY | Boehringer Ingelheim Pharmaceuticals Inc (USA) |
| Reference | Meaning |
|---|---|
| CATAPRES-TTS-1 | 5/1 Secondary reference Boehringer Ingelheim Pharmaceuticals Inc |
NSN 6505-01-224-3319 is a Clonidine Transdermal System, manufactured by Boehringer Ingelheim Pharmaceuticals Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-224-3319 has 2 manufacturer part numbers on file: 3112 (Boehringer Ingelheim Pharmaceuticals Inc), NDC00597-0031-12 (Boehringer Ingelheim Pharmaceuticals Inc).
Key specifications for 3112: Usual Dose: 0.1 MG RELEASED PER DAYY FOR 7 DAYS; Features Provided: BANDAGE, ADHESIVE, NONSENSITIZED; Overall Strength in System: 2.55 MG CLONIDINE ACTIVE INGREDIENT; Special Features: A TRANSDERMAL RESERVOIR SYSTEM W/A MICROPORUS POLYPROPYLENE MEMBRANE THAT CONTROLS THE RATE OF DELIVERY OF CLONIDINE FROM THE SYSTEM TO THE SKIN SURFACE; W/12 ADHESIVE OVERLAYS. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.